Regulatory Rapporteur July Aug 2010
Volume 7 Issue 7
In This Issue
- PHARMACOVIGILANCE
- Charting adverse events in Austria
- The importance of safety data in PILs
- PLUS:
- Interview: Dr Hartmut Krafft, Co-Chair of the CTFG
- Update on traditional herbal medicines legislation
- Should GI control techniques be reappraised?
Please login to download articles. Non-members may download the Focus article.
| Title | Download | Category | Size | File |
|---|---|---|---|---|
| Regulatory Rapporteur July Aug 2010 | Members | Full Issue | 3MB | |
| EU regulatory update: March–May 2010 | Public | 488KB | ||
| Controlling genotoxic impurities – should the techniques be revisited? | Members | 497KB | ||
| First, do no harm | Members | 474KB | ||
| One voice for clinical trials in Europe | Members | 547KB | ||
| Overview and update on EU directive 2004/24/EC: Traditional herbal medicines | Members | 649KB | ||
| Pharmacovigilance in Austria 2006–2010: A brief account of an evolutionary process | Members | 653KB | ||
| The link between PIL user testing and pharmacovigilance | Members | 605KB | ||
| The Medical Devices Exchange | Members | 468KB |
